Unknown

Dataset Information

0

Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.

ABSTRACT:

SUBMITTER: Purroy N 

PROVIDER: S-EPMC8990375 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Genomics Single Cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
| PRJNA782728 | ENA
Genomics Single Cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
| PRJNA782729 | ENA
Unknown Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL.
| S-EPMC6989523 | biostudies-literature
Unknown Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.
| S-EPMC7785110 | biostudies-literature
Genomics Ibrutinib in CLL
| PRJEB32120 | ENA
Unknown Ibrutinib treatment improves T cell number and function in CLL patients.
| S-EPMC5531425 | biostudies-literature
Unknown Single-Cell Transcriptomics Reveals Biomarkers for NK Cell Dysfunction in Endometriosis-Associated Immune Dysregulation.
| S-EPMC12866336 | biostudies-literature
Unknown PDCD1 as a targetable immune checkpoint hub: therapeutic insights for ibrutinib-resistant CLL management.
| S-EPMC12628378 | biostudies-literature
Unknown Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib.
| S-EPMC5064717 | biostudies-literature
Unknown Single-cell RNA sequencing of peripheral blood reveals immune cell dysfunction in premature ovarian insufficiency.
| S-EPMC10200870 | biostudies-literature